Olivier Zava

2.3k total citations
32 papers, 2.0k citations indexed

About

Olivier Zava is a scholar working on Organic Chemistry, Oncology and Materials Chemistry. According to data from OpenAlex, Olivier Zava has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 22 papers in Oncology and 8 papers in Materials Chemistry. Recurrent topics in Olivier Zava's work include Metal complexes synthesis and properties (22 papers), Ferrocene Chemistry and Applications (15 papers) and Supramolecular Chemistry and Complexes (8 papers). Olivier Zava is often cited by papers focused on Metal complexes synthesis and properties (22 papers), Ferrocene Chemistry and Applications (15 papers) and Supramolecular Chemistry and Complexes (8 papers). Olivier Zava collaborates with scholars based in Switzerland, France and Canada. Olivier Zava's co-authors include Paul J. Dyson, Bruno Therrien, Nicolas P. E. Barry, Michael Groessl, Angela Casini, Georg Süß‐Fink, Johan Mattsson, Alexey A. Nazarov, Robert Deschenaux and Anaïs Pitto‐Barry and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Olivier Zava

32 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivier Zava Switzerland	28	1.4k	1.2k	468	415	317	32	2.0k
Anna K. Renfrew Switzerland	25	1.6k 1.1×	1.3k 1.1×	628 1.3×	610 1.5×	330 1.0×	39	2.4k
P. Govindaswamy Switzerland	20	1.4k 0.9×	733 0.6×	673 1.4×	484 1.2×	168 0.5×	33	1.8k
Maria V. Babak Hong Kong	23	1.2k 0.8×	1.3k 1.1×	314 0.7×	336 0.8×	490 1.5×	64	2.2k
Luca Ronconi Italy	26	2.1k 1.4×	2.3k 1.9×	552 1.2×	492 1.2×	680 2.1×	49	3.3k
Peter J. Barnard Australia	27	2.4k 1.6×	849 0.7×	341 0.7×	520 1.3×	506 1.6×	66	3.3k
Patrick C. McGowan United Kingdom	23	1.9k 1.3×	775 0.6×	640 1.4×	358 0.9×	245 0.8×	72	2.5k
Annalisa Guerri Italy	27	920 0.6×	894 0.7×	492 1.1×	528 1.3×	328 1.0×	79	1.9k
Adoración G. Quiroga Spain	29	1.6k 1.1×	1.9k 1.5×	374 0.8×	458 1.1×	524 1.7×	83	2.5k
Marı́a Contel United States	38	2.2k 1.5×	1.2k 1.0×	636 1.4×	446 1.1×	424 1.3×	78	3.0k
I. Bratsos Italy	21	1.0k 0.7×	1.2k 1.0×	384 0.8×	431 1.0×	388 1.2×	36	1.8k

Countries citing papers authored by Olivier Zava

Since Specialization

Citations

This map shows the geographic impact of Olivier Zava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Zava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Zava more than expected).

Fields of papers citing papers by Olivier Zava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Zava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Zava. The network helps show where Olivier Zava may publish in the future.

Co-authorship network of co-authors of Olivier Zava

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Zava. A scholar is included among the top collaborators of Olivier Zava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Zava. Olivier Zava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riedel, Tina, et al.. (2017). Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment. Molecular Pharmaceutics. 15(1). 116–126. 15 indexed citations

Nazarov, Alexey A., Mathurin Baquié, Patrycja Nowak‐Sliwinska, et al.. (2013). Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters. Scientific Reports. 3(1). 1485–1485. 42 indexed citations

Khan, Farooq‐Ahmad, Bruno Therrien, Georg Süß‐Fink, Olivier Zava, & Paul J. Dyson. (2012). Arene ruthenium dichloro complexes containing isonicotinic ester ligands: Synthesis, molecular structure and cytotoxicity. Journal of Organometallic Chemistry. 730. 49–56. 17 indexed citations

Nazarov, Alexey A., Wee Han Ang, Frédéric Schmitt, et al.. (2012). Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds. Inorganic Chemistry. 51(6). 3633–3639. 48 indexed citations

Zava, Olivier, Benoı̂t Bertrand, Claire Bernhard, et al.. (2012). BODIPY–phosphane as a versatile tool for easy access to new metal-based theranostics. Dalton Transactions. 42(17). 6102–6109. 51 indexed citations

Giannini, Federico, Julien Furrer, Georg Süß‐Fink, et al.. (2012). Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential. JBIC Journal of Biological Inorganic Chemistry. 17(6). 951–960. 61 indexed citations

Barry, Nicolas P. E., Olivier Zava, Paul J. Dyson, & Bruno Therrien. (2011). Excellent Correlation between Drug Release and Portal Size in Metalla‐Cage Drug‐Delivery Systems. Chemistry - A European Journal. 17(35). 9669–9677. 88 indexed citations

Groessl, Michael, Olivier Zava, & Paul J. Dyson. (2011). Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin. Metallomics. 3(6). 591–591. 122 indexed citations

Clavel, Catherine M., Olivier Zava, Frédéric Schmitt, et al.. (2011). Thermoresponsive Chlorambucil Derivatives for Tumour Targeting. Angewandte Chemie International Edition. 50(31). 7124–7127. 28 indexed citations

10.

Pitto‐Barry, Anaïs, Nicolas P. E. Barry, Olivier Zava, Robert Deschenaux, & Bruno Therrien. (2011). Encapsulation of Pyrene‐Functionalized Poly(benzyl ether) Dendrons into a Water‐Soluble Organometallic Cage. Chemistry - An Asian Journal. 6(6). 1595–1603. 57 indexed citations

11.

Pitto‐Barry, Anaïs, Nicolas P. E. Barry, Olivier Zava, et al.. (2011). Double Targeting of Tumours with Pyrenyl‐Modified Dendrimers Encapsulated in an Arene–Ruthenium Metallaprism. Chemistry - A European Journal. 17(6). 1966–1971. 74 indexed citations

12.

Pelletier, Frédéric, Virginie Comte, Margot N. Wenzel, et al.. (2010). Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties. Journal of Medicinal Chemistry. 53(19). 6923–6933. 85 indexed citations

13.

Barry, Nicolas P. E., Olivier Zava, Paul J. Dyson, & Bruno Therrien. (2010). Synthesis, Characterization and Anticancer Activity of Porphyrin-Containing Organometallic Cubes. Australian Journal of Chemistry. 63(11). 1529–1537. 38 indexed citations

14.

Mattsson, Johan, Olivier Zava, Anna K. Renfrew, et al.. (2010). Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage. Dalton Transactions. 39(35). 8248–8248. 74 indexed citations

15.

Gras, M., Bruno Therrien, Georg Süß‐Fink, Olivier Zava, & Paul J. Dyson. (2010). Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents. Dalton Transactions. 39(42). 10305–10305. 77 indexed citations

16.

Barry, Nicolas P. E., Olivier Zava, Julien Furrer, Paul J. Dyson, & Bruno Therrien. (2010). Anticancer activity of opened arene ruthenium metalla-assemblies. Dalton Transactions. 39(22). 5272–5272. 77 indexed citations

17.

Mühlgassner, Gerhard, Michael A. Jakupec, Olivier Zava, et al.. (2009). Highly Cytotoxic Copper(II) Complexes with Modified Paullone Ligands. Inorganic Chemistry. 49(1). 302–311. 47 indexed citations

18.

Vergara, Elena, Angela Casini, Francesca Sorrentino, et al.. (2009). Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands. ChemMedChem. 5(1). 96–102. 111 indexed citations

19.

Schmitt, Frédéric, P. Govindaswamy, Olivier Zava, et al.. (2008). Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy. JBIC Journal of Biological Inorganic Chemistry. 14(1). 101–109. 90 indexed citations

20.

Hanif, Muhammad, Alexey A. Nazarov, Christian G. Hartinger, et al.. (2008). In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate‐Based Ligands. Chemistry - A European Journal. 14(29). 9046–9057. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact